Open Orphan plc (LON:ORPH) Executive Chairman Cathal Friel joins DirectorsTalk Interviews to discuss results from the world’s first COVID-19 characterisation study. Cathal explains what these results mean for Open Orphan, plans to initiate the next phase of the Human Challenge Programme, studies to approve new vaccines and antivirals and with 95% of 2022 targeted revenues … Continue reading Open Orphan world’s first COVID-19 characterisation study (Interview)